UroUpdate
@uroupdate
ID: 3351255280
http://www.med-update.com 29-06-2015 21:11:51
1,1K Tweet
1,1K Followers
1,1K Following
News: Obesity is associated with an increased risk for any-grade immune-related adverse events among people receiving nivolumab for advanced cancer, suggests research by Dr. Jennifer McQuade Hans Hammers Robert Motzer MD et al in JAMA Oncology UroUpdate MD Anderson Cancer Center bit.ly/3BLjt02
When should we de-escalate or intensify treatment in mCSPC patients? Presenting the perfect discourse based on current data! Axel S. Merseburger ESMO - Eur. Oncology European Association of Urology (EAU) Medscape OncoAlert #EMUC23
#UroUpdate 2024 - Berlin 16.-17. Februar 2024 - safe the Date! #Berlin #Urologie #UroUpdate24 BvDUrologie GeSRU Christian Wülfing Julian Struck Hannah Arnold Axel S. Merseburger Christian Gratzke UroFors Martin Schostak, MD PhD Inga Peters Anmeldung unter: uro-update.com
#APCCC24 Lugano 2024 👏- Unique way to learn and chat with the world experts on #ProstateCancer Registration on apccc.org European Association of Urology (EAU) UroUpdate GeSRU Advanced Prostate Cancer Consensus Conference Misha Beltran Elena Castro Yüksel Ürün Anders Bjartell
Full FDA approval for #Erdafitinib for the treatment of pts with locally advanced/metastatic FGFR+ #UrothelialCarcinoma following prior systemic therapy, based on data from THOR/Cohort 1): 36% risk reduction in death in pts with prior PD1/PDL1 inhibition vs chemo J&J Innovative Medicine
Looking forward to #GU24 ASCO amazing conference starting this week to meet colleagues and friends OncoAlert UroToday.com European Association of Urology (EAU) DGU medudy #virtualavatar
NECTIN4 amplification predicts response to Enfortumab vedotin in mUC! It occurs frequently across solid tumors (app. 25% of mUC)➡️potential tumor-agnostic biomarker for NECTIN4-targeting therapies! Happy to share our poster K17 ASCO #GU24! Markus Eckstein OncoAlert UroToday.com
INSIGHT PROSTATE App jetzt verfügbar! Entdecke die interaktive #AugmentedReality -App, die den #Prostatakrebs durch eindrucksvolle Animationen und barrierearme Sprache verständlicher macht. Entwickelt mit Prof. Axel S. Merseburger . Kostenlos in allen App-Stores bit.ly/3vAkQhS
#UroUpdate started nächsten Freitag - noch wenige Plätze frei! DGU DGU Kongress GeSRU Academics GeSRU
Updated analysis showing ctDNA as potentially predictive and prognostic marker after cystectomy in muscle invasive bladder cancer. CtDNA clearance also looks important. New data on relapse rates in ctDNA-ve with be #EAU24 joaquim bellmunt European Urology
Gelungener Start #UroUpdate 2024 - Berlin 16.-17.02. #Berlin #Urologie #UroUpdate24 BvDUrologie GeSRU Christian Wülfing Julian Struck Hannah Arnold Axel S. Merseburger Christian Gratzke UroFors Martin Schostak, MD PhD Inga Peters
Great start of #EAU24 catching up with friends and colleges. Congrats 👏🏼 to EAU team for smooth start and all hard work European Association of Urology (EAU) OncoAlert UroToday.com Arnulf Stenzl Maria J. Ribal James N'Dow Morgan Roupret
Fantastic start of #APCCC perfect also in virtual format for the ones that couldn’t make it to #Lugano #Apccc24 Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin OncoAlert Thomas Zilli Derya Tilki, MD Daniel Castellano Rana McKay, MD, FASCO Piet Ost Dra. María Natalia Gandur Quiroga Deborah Mukherji Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran
Out now! "Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy" BJU International Simon C Neeraj Agarwal, MD, FASCO Sabine D. Brookman-May Anders Bjartell bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
Honored to share my Urologist’s perspective at ESMO-SIOG: Working together in the era of personalized care for older adults with cancer session Join us on Monday, 16 Sep 2024 - 08:30 - 10:00 Toledo Auditorium - Hall 3 ESMO - Eur. Oncology OncoAlert #ESMO24 Ravindran Kanesvaran #mHSPC
